The outstanding share count looks great overall. Almost makes me not want the Reg A to happen. If it does, hopefully the growth for the business offsets the additional outstanding shares added.
But somehow that Reg A may help this grow all the way to human trials and beyond. If so, that is worth the outstanding share count to add the 150 million additional shares.